4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-046791
EVP, Chief Operating Officer acquired 1,530 shares (other)
- EVP, Chief Operating Officer gave up 433 shares (to pay taxes)
- EVP, Chief Operating Officer acquired 1,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Szekeres David Leslie EVP, Chief Operating Officer | 2021-04-30 | Other acquisition | +1,530 | $13.90 | $21,263 | 2,347 | D |
| Szekeres David Leslie EVP, Chief Operating Officer | 2021-07-13 | Option exercise | +1,250 | 3,597 | D | ||
| Szekeres David Leslie EVP, Chief Operating Officer | 2021-07-13 | Shares withheld for taxes | −433 | $13.48 | $5,837 | 3,164 | D |
| Derivatives | |||||||
| Szekeres David Leslie EVP, Chief Operating Officer | 2021-07-13 | Option exercise · Restricted Stock Units | −1,250 | 16,250 | D | ||
Loading xslF345X03/doc4.xml…